Skip to main content

Animations

MJFF Publications

1471 - 1480 of 8666 Results
Title
Year
  • Year
  • 2017
  • 2012
  • 2018
  • 2015
  • 2014
  • 2018
  • 2013
  • 2013
  • 2015
  • 2018
  • Summary Details
    OPEN
    Title: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2017.6669
    Citation Count: 399
  • Summary Details
    OPEN
    Title: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms1669
    Citation Count: 243
  • Summary Details
    OPEN
    Title: CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.01.010
    Citation Count: 664
  • Summary Details
    OPEN
    Title: Tau positron emission tomographic imaging in aging and early Alzheimer disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24546
    Best OA location URL:
    Citation Count: 878
  • Summary Details
    OPEN
    Title: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms4633
    Citation Count: 282
  • Summary Details
    OPEN
    Title: Prevalence of Parkinson’s disease across North America
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0058-0
    Citation Count: 883
  • Summary Details
    OPEN
    Title: Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nature12043
    Citation Count: 956
  • Summary Details
    OPEN
    Title: Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awt192
    Citation Count: 1156
  • Summary Details
    OPEN
    Title: Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal PINK 1‐dependent phosphorylation and activation
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201540352
    Citation Count: 230
  • Summary Details
    OPEN
    Title: TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-017-0047-3
    Citation Count: 527
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.